Table 2 Descriptive statistics
From: Symptom clusters among cancer survivors: what can machine learning techniques tell us?
Mean | SD | N | % | ||
|---|---|---|---|---|---|
Age | 60.52 | 11.31 | |||
Gender | Female | 701 | 67.99% | ||
Male | 330 | 32.01% | |||
Education | Elementary school | 24 | 2.33% | ||
High school | 164 | 15.91% | |||
Vocational education | 590 | 57.23% | |||
College | 115 | 11.15% | |||
University | 107 | 10.38% | |||
Post-doctoral | 23 | 2.23% | |||
Other | 8 | 0.78% | |||
Cancer type | Breast cancer | 504 | 48.88% | ||
Colon cancer | 182 | 17.65% | |||
Lymphoma | 73 | 7.08% | |||
Head and neck cancer | 60 | 5.82% | |||
Rectal cancer | 40 | 3.88% | |||
Other | 39 | 3.78% | |||
Lung cancer | 31 | 3.01% | |||
Prostate cancer | 29 | 2.81% | |||
Gynecologic cancer | 20 | 1.94% | |||
Bladder or kidney cancer | 17 | 1.65% | |||
Skin cancer | 11 | 1.07% | |||
Blood cancer | 9 | 0.87% | |||
Esophageal cancer | 5 | 0.48% | |||
Brain cancer | 4 | 0.39% | |||
Pancreatic or liver cancer | 4 | 0.39% | |||
Stomach cancer | 3 | 0.29% | |||
Treatment status | Treatment completed | 614 | 59.55% | ||
Currently being treated | 172 | 16.68% | |||
Not yet treated | 94 | 9.12% | |||
Unknown | 80 | 7.76% | |||
No treatment | 71 | 6.89% | |||
Treatment type | Surgical | 743 | 79.04% | ||
Chemotherapy | 103 | 10.96% | |||
Radiation | 38 | 4.04% | |||
Chemoradiation | 24 | 2.55% | |||
Other | 10 | 1.06% | |||
Hormone therapy | 7 | 0.74% | |||
Wait-and-see | 7 | 0.74% | |||
Immunotherapy | 4 | 0.43% | |||
Unknown | 4 | 0.43% |